Oncolytics Biotech announces successful End-of-Phase 2 meeting with FDA for REOLYSIN in metastatic breast cancer September 18, 2017 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Leading Brands to acquire Liquid Media Group Back: All Posts Next:RCI panel draws to a close, final witness unable to testify